Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 4.66% to $5.52 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index ...

Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the Phase 1 trial of CRB-913 for the treatment of obesity ...

With most of the dust settling from the free agency frenzy, teams' roster needs for the 2025 NFL Draft (April 24-26 in Green Bay, Wisconsin) are coming into focus. Here's the current order for ...

Products are independently selected by our editors. We may earn an affiliate commission from links. True skin-care enthusiasts will tell you that the secret to achieving smooth, even-toned, dewy ...

Life expectancy can be increased simply by going outside and getting some sun. Exposure to sunlight triggers cells in your skin to produce vitamin D. Vitamin D deficiency can impair all of these ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a biopharmaceutical company currently valued at $71 million, announced on Thursday that Dr. Peter Salzmann has decided not to seek re-election to ...

Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.7% over the past four weeks, the stock looks well positioned for a trend ...

For a look at everything Larian fine-tuned in this latest Patch 8 update for stress testers, check out the full patch notes as shared via Steam below.

Like many of you, I understand the challenge of fitting exercise into a busy schedule. When life gets hectic, finding time for 10,000 steps can seem impossible. But over the years, I've developed ...